Life Image and Mendel.ai Partner to Bring the Power of AI to Accelerate Clinical Trial Process for Life Sciences and Academic Medical Facilities
Summary
NEWTON, Mass.--( BUSINESS WIRE )-- Life Image , the worlds largest global network for sharing clinical and imaging data that is powered by industry leading interoperability standards, and Mendel.ai , a novel AI platform built to turbocharge oncology clinical research by rigorously examining every piece of EMR data, today announced a new strategic partnership that will facilitate the adoption and enhancement of AI in site selection and patient recruitment for oncology trials.This new engagement will advance the use of Mendel Brain, which helps life sciences and research facilities by analyzing clinical data at a site location to identify patient cohorts for a given protocol.With the depth and breadth of Life Image’s network of Academic Medical Centers (AMC), the Mendel Brain solution is in high demand to reduce the administrative burdens of clinical trial participation.“Assembling clinical trials has long posed significant challenges for both our core customers as well as the healthcare industry as a whole,” said Matthew A. Michela, President and CEO, Life Image.Founded in 2008, Life Image has spent the past decade innovating and building an interoperable network ecosystem connecting hospitals, physicians, patients, pharmaceuticals, medical device, telehealth and EHRs.
Classifications
AskAI Classifications
LabelsLinked Companies
